Fri, Aug 22, 2014, 12:03 AM EDT - U.S. Markets open in 9 hrs 27 mins

Recent

% | $
Quotes you view appear here for quick access.

Exelixis, Inc. Message Board

  • gvsteelman gvsteelman Dec 19, 2012 8:08 PM Flag

    Another Insider Purchase

    obligations may
    continue. See Instruction
    1(b).
    1. Name and Address of Reporting Person *
    MARCHESI VINCENT T
    (Last) (First) (Middle)
    C/O EXELIXIS, INC., 210 E. GRAND AVE.
    (Street)
    SOUTH SAN
    FRANCISCO CA 94080
    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    EXELIXIS, INC. [EXEL]
    5. Relationship of Reporting Person(s) to
    Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give
    title below)
    Other
    (specify
    below)
    3. Date of Earliest Transaction
    (Month/Day/Year)
    12/17/2012
    4. If Amendment, Date of Original Filed
    (Month/Day/Year)
    6. Individual or Joint/Group Filing
    (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One
    Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1.Title of
    Security
    (Instr. 3)
    2. Transaction
    Date
    (Month/Day/Year)
    2A. Deemed
    Execution Date,
    if any
    (Month/Day/Year)
    3.
    Transaction
    Code
    (Instr. 8)
    4. Securities Acquired
    (A) or Disposed of (D)
    (Instr. 3, 4 and 5)
    5. Amount of
    Securities
    Beneficially
    Owned
    Following
    Reported
    Transaction(s)
    (Instr. 3 and
    4)
    6.
    Ownership
    Form:
    Direct (D)
    or Indirect
    (I)
    (Instr. 4)
    7. Nature
    of Indirect
    Beneficial
    Ownership
    (Instr. 4)
    Code V Amount
    (A)
    or
    (D) Price
    Common
    Stock 12/17/2012 P 3,000 A $ 4.6975 18,000 D
    Common
    Stock 12/18/2012 P 1,500 A $ 4.8199 19,500 D
    Stock 12/19/2012 P 1,500 A $ 4.67 21,000 D

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • $$$$

      From the EXEL website....

      "Vincent T. Marchesi, M.D., Ph.D. has been a director since May 2001. Since 1973, Dr. Marchesi has been a Professor of Pathology and Cell Biology at Yale University and, since 1991, the Director of the Boyer Center for Molecular Medicine at Yale University. In 1982, Dr. Marchesi co-founded Molecular Diagnostics, Inc., a diagnostic development company. Dr. Marchesi was formerly Chair of Pathology at the Yale-New Haven Hospital. Dr. Marchesi holds an M.D. from Yale University and a Ph.D. from Oxford University, and is a member of the National Academy of Sciences and the Institute of Medicine"

      Just another knucklehead buying into something of which he knows next to nothing.
      Anybody gettin' the warm fuzzies over these insider buys...??
      GLTA

 
EXEL
4.09-0.02(-0.49%)Aug 21 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.